Paul P et al. |
Capillary electrophoresis with capacitively coupled contactless conductivity detection method development and validation for the determination of azithromycin, clarithromycin, and clindamycin. |
2017 |
J Sep Sci |
pmid:28683179
|
Morimoto K et al. |
A Laboratory-based Analysis of Nontuberculous Mycobacterial Lung Disease in Japan from 2012 to 2013. |
2017 |
Ann Am Thorac Soc |
pmid:27788025
|
Wong AYS et al. |
Managing Cardiovascular Risk of Macrolides: Systematic Review and Meta-Analysis. |
2017 |
Drug Saf |
pmid:28397186
|
Baluch A et al. |
Successful management of Mycobacterium haemophilum lower extremity cutaneous infection in a matched-unrelated donor stem cell transplant recipient. |
2017 |
Transpl Infect Dis |
pmid:27775824
|
Aziz DB et al. |
Rifabutin Is Active against Mycobacterium abscessus Complex. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28396540
|
Maruyama M et al. |
Vonoprazan-Based Regimen Is More Useful than PPI-Based One as a First-Line Eradication: A Randomized Controlled Trial. |
2017 |
Can J Gastroenterol Hepatol |
pmid:28349044
|
Brouqui P et al. |
Old antibiotics for emerging multidrug-resistant/extensively drug-resistant tuberculosis (MDR/XDR-TB). |
2017 |
Int. J. Antimicrob. Agents |
pmid:28336312
|
Xu YF et al. |
and Antibacterial Activities of Patchouli Alcohol, a Naturally Occurring Tricyclic Sesquiterpene, against Helicobacter pylori Infection. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28320722
|
Yang YJ et al. |
Ten days of levofloxacin-containing concomitant therapy can achieve effective Helicobacter pylori eradication in patients with type 2 diabetes. |
2017 |
Ann. Med. |
pmid:28266875
|
Yoon HY et al. |
Clinical significance of QT-prolonging drug use in patients with MDR-TB or NTM disease. |
2017 |
Int. J. Tuberc. Lung Dis. |
pmid:28826448
|
Yoon H et al. |
Eradication Downregulates Cellular Inhibitor of Apoptosis Protein 2 in Gastric Carcinogenesis. |
2017 |
Gut Liver |
pmid:27282269
|
Santos RP et al. |
induced rash and mucositis: a recently described entity. |
2017 |
BMJ Case Rep |
pmid:28830900
|
Kwon S et al. |
[The Efficacy of Moxifloxacin-containing Triple Therapy after Hybrid Therapy Failure in Eradication]. |
2017 |
Korean J Gastroenterol |
pmid:28830132
|
Nanishi E et al. |
Clarithromycin Plus Intravenous Immunoglobulin Therapy Can Reduce the Relapse Rate of Kawasaki Disease: A Phase 2, Open-Label, Randomized Control Study. |
2017 |
J Am Heart Assoc |
pmid:28684643
|
Boal Carvalho P et al. |
Randomized Controlled Trial for Helicobacter pylori Eradication in a Naive Portuguese Population: Is Sequential Treatment Superior to Triple Therapy in Real World Clinical Setting? |
2017 |
Acta Med Port |
pmid:28550827
|
Shah SA et al. |
Clarithromycin inhibits TNF-α-induced MUC5AC mucin gene expression via the MKP-1-p38MAPK-dependent pathway. |
2017 |
Int. Immunopharmacol. |
pmid:28550735
|
Jakubů V et al. |
Trends in the Minimum Inhibitory Concentrations of Erythromycin, Clarithromycin, Azithromycin, Ciprofloxacin, and Trimethoprim/Sulfamethoxazole for Strains of Bordetella pertussis isolated in the Czech Republic in 1967-2015. |
2017 |
Cent. Eur. J. Public Health |
pmid:29346850
|
Vaz AM et al. |
Capsule endoscopy in the diagnosis of disseminated complex infection. |
2017 |
BMJ Case Rep |
pmid:29167222
|
Lee H et al. |
Concomitant, sequential, and 7-day triple therapy in first-line treatment of Helicobacter pylori infection in Korea: study protocol for a randomized controlled trial. |
2017 |
Trials |
pmid:29149904
|
Fremlin GA et al. |
Clarithromycin, rifampicin and fusidic acid triple combination therapy for chronic folliculocentric pustulosis of the scalp. |
2017 |
Clin. Exp. Dermatol. |
pmid:28691163
|
Andere NMRB et al. |
Clarithromycin as an Adjunct to One-Stage Full-Mouth Ultrasonic Periodontal Debridement in Generalized Aggressive Periodontitis: A Randomized Controlled Clinical Trial. |
2017 |
J. Periodontol. |
pmid:28671507
|
Adachi T et al. |
Comparative Study of Clarithromycin- versus Metronidazole-Based Triple Therapy as First-Line Eradication for Helicobacter pylori. |
2017 |
Oncology |
pmid:29258111
|
Moon SH et al. |
Novel Linear Lipopeptide Paenipeptins with Potential for Eradicating Biofilms and Sensitizing Gram-Negative Bacteria to Rifampicin and Clarithromycin. |
2017 |
J. Med. Chem. |
pmid:29136469
|
Feng L et al. |
Removal of antibiotics during the anaerobic digestion of pig manure. |
2017 |
Sci. Total Environ. |
pmid:28628813
|
Freyne B and Curtis N |
Mycobacterium gordonae Skin Infection in an Immunocompetent Child. |
2017 |
Pediatr. Infect. Dis. J. |
pmid:28403059
|
Bustamante-Rengifo JA et al. |
Effect of treatment failure on the CagA EPIYA motif in strains from Colombian subjects. |
2017 |
World J. Gastroenterol. |
pmid:28373764
|
Marin AC et al. |
Efficacy and Safety of Quinolone-Containing Rescue Therapies After the Failure of Non-Bismuth Quadruple Treatments for Helicobacter pylori Eradication: Systematic Review and Meta-Analysis. |
2017 |
Drugs |
pmid:28361211
|
Holmberg LA et al. |
Results from Two Consecutive Studies of Consolidation Therapy after Autologous Transplant for Multiple Myeloma: Thalidomide, Dexamethasone, and Clarithromycin or Lenalidomide, Dexamethasone, and Clarithromycin. |
2017 |
Acta Haematol. |
pmid:28355602
|
Smith S et al. |
The Irish Helicobacter pylori Working Group consensus for the diagnosis and treatment of H. pylori infection in adult patients in Ireland. |
2017 |
Eur J Gastroenterol Hepatol |
pmid:28350745
|
Mougari F et al. |
Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria. |
2017 |
J. Antimicrob. Chemother. |
pmid:28333340
|
Chen PY et al. |
Letter: levofloxacin resistance - a challenge for treatment of Helicobacter pylori infection. Authors' reply. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28074519
|
Zamani M et al. |
Letter: levofloxacin resistance - a challenge for the treatment of Helicobacter pylori infection. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28074507
|
Chey WD et al. |
ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. |
2017 |
Am. J. Gastroenterol. |
pmid:28071659
|
Fernández Martos R et al. |
Acute psychotic episode secondary to Helicobacter pylori eradication treatment. |
2017 |
Rev Esp Enferm Dig |
pmid:28071063
|
Ko J et al. |
Delayed onset Mycobacterium intracellulare keratitis after laser in situ keratomileusis: A case report and literature review. |
2017 |
Medicine (Baltimore) |
pmid:29390522
|
Takeuchi S et al. |
Hypotension induced by the concomitant use of a calcium-channel blocker and clarithromycin. |
2017 |
BMJ Case Rep |
pmid:28069789
|
Vianna JS et al. |
The interplay between mutations in cagA, 23S rRNA, gyrA and drug resistance in Helicobacter pylori. |
2018 |
Rev. Inst. Med. Trop. Sao Paulo |
pmid:29972462
|
Myojin S et al. |
Chronic otitis media caused by Mycobacterium abscessus spp. massiliense treated with tigecycline in a 10-year-old child. |
2018 |
Int. J. Infect. Dis. |
pmid:29966711
|
Liou JM et al. |
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection. |
2018 |
Gastroenterology |
pmid:29964036
|
Kwofie SK et al. |
Screening of Isocitrate Lyase for Novel Anti-Buruli Ulcer Natural Products Originating from Africa. |
2018 |
Molecules |
pmid:29954088
|
Tanabe H et al. |
Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication. |
2018 |
Ann. Clin. Microbiol. Antimicrob. |
pmid:29950163
|
Fiorini G et al. |
Pylera and sequential therapy for first-line Helicobacter pylori eradication: a culture-based study in real clinical practice. |
2018 |
Eur J Gastroenterol Hepatol |
pmid:29481383
|
Talarico S et al. |
High prevalence of Helicobacter pylori clarithromycin resistance mutations among Seattle patients measured by droplet digital PCR. |
2018 |
Helicobacter |
pmid:29480566
|
Takemori N et al. |
A novel combination of bortezomib, lenalidomide, and clarithromycin produced stringent complete response in refractory multiple myeloma complicated with diabetes mellitus - clinical significance and possible mechanisms: a case report. |
2018 |
J Med Case Rep |
pmid:29454372
|
Zagari RM et al. |
Treatment of Helicobacter pylori infection: A clinical practice update. |
2018 |
Eur. J. Clin. Invest. |
pmid:29144559
|
Liu DS et al. |
Primary antibiotic resistance of Helicobacter pylori in Chinese patients: a multiregion prospective 7-year study. |
2018 |
Clin. Microbiol. Infect. |
pmid:29138101
|
Redondo JJ et al. |
A novel RT-PCR for the detection of Helicobacter pylori and identification of clarithromycin resistance mediated by mutations in the 23S rRNA gene. |
2018 |
Diagn. Microbiol. Infect. Dis. |
pmid:29111147
|
Iwamoto J et al. |
Effects of the Concomitant Use of Low-dose Clarithromycin with an Anti-TNFα Antibody in a Patient with Intestinal Behçet Disease. |
2018 |
Intern. Med. |
pmid:29093413
|
Ullah S et al. |
Hydrophilically modified self-assembling α-tocopherol derivative as niosomal nanocarrier for improving clarithromycin oral bioavailability. |
2018 |
Artif Cells Nanomed Biotechnol |
pmid:28541761
|
Cheung KS et al. |
Long-term proton pump inhibitors and risk of gastric cancer development after treatment for : a population-based study. |
2018 |
Gut |
pmid:29089382
|